Canna Therapeutic is a biotechnology and phyto-science company discovering, developing, and commercializing pharma-grade cannabinoid-based medicines. Its portfolio comprises APIs (active pharmaceutical ingredients) from cannabis compounds as well as drug candidates, originating from the cannabis plant. The company focuses on neuropathic pain, inflammatory bowel disease, post-traumatic stress disorder, epileptic seizures, and other indications.